Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1, single-center, randomized, comparative trial of single doses of IV rezafungin, IV placebo, and oral moxifloxacin (positive control) in healthy adult subjects

Trial Profile

Phase 1, single-center, randomized, comparative trial of single doses of IV rezafungin, IV placebo, and oral moxifloxacin (positive control) in healthy adult subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Oct 2018

At a glance

  • Drugs Rezafungin (Primary) ; Moxifloxacin
  • Indications Aspergillosis; Candidiasis
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Oct 2018 New trial record
    • 07 Oct 2018 Results presented at the IDWeek 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top